Algestone Acetophenide

Algestone Acetophenide

SCHEMBL1649218

CC(=O)[C@@]12OC(C)(c3ccccc3)O[C@@H]1C[C@H]1C3CCC4=CC(=O)CCC4(C)[C@H]3CCC12C

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 2/20 0.76
▸ SERPINA6 P08185 4/20 0.56
▸ SHBG P04278 6/20 0.55
▸ LMNA P02545 5/20 0.55
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ NR3C1 P04150 4/20 0.55
▸ CYP2C19 P33261 4/20 0.55
▸ MAPT P10636 3/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ ADORA3 P0DMS8 2/20 0.55
▸ BLM P54132 2/20 0.55
▸ MAPK3 P27361 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.51
▸ PGR P06401 3/20 0.51
▸ ADRA1A P35348 2/20 0.51
▸ HTR2B P41595 2/20 0.51
▸ CYP3A4 P08684 4/20 0.48
▸ TSHR P16473 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Algestone Acetophenide SCHEMBL282250 1.00 CYP17A1 (0.76) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
Algestone Acetophenide SCHEMBL3039564 1.00 CYP17A1 (0.76) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
Algestone Acetonide SCHEMBL42582 0.87 CYP17A1 (0.85) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL29500568 0.87 CYP17A1 (1.00) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL29409283 0.87 CYP17A1 (1.00) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL4541005 0.87 CYP17A1 (1.00) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL7993136 0.87 CYP17A1 (1.00) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL4539514 0.87 CYP17A1 (1.00) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL151266 0.77 CYP17A1 (0.76) CYP17A1SERPINA6SHBGLMNASMN1; SMN2
SCHEMBL19505758 0.76 SHBG (0.53) CYP17A1SERPINA6SHBGLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114085261-A Preparation method of megestrol and intermediate thereof 浙江仙琚制药股份有限公司 2022-02-25 — — CN disclosed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 — — US disclosed
US-7790905-B2 Pharmaceutical propylene glycol solvate compositions MCNEIL-PPC, INC. (US) 2010-09-07 — — US disclosed
Send feedback